Etudes Non Stop Study Non Stop
Related Articles
Would you like to leverage your bioinformatics- and data science skills to identify new drug targets for cardiometabolic disease, and are you motivated by the idea of being part of a team committed to having fun while working on hard problems or treading off the beaten trail? Then you may be the new colleague we are looking for to join our Computational Biology Department.
About Novo Nordisk & Novo Nordisk Research Centre Oxford (NNRCO)
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. We employ more than 42,000 people in 80 countries and market our products in around 170 countries. NNRCO is Novo Nordisk’s new Translational Research Unit (TRU) focused on biology and target discovery across the broad spectrum of cardiometabolic disease. Our mission is to be a world-leading research site focused on asking the big and difficult questions and delivering high impact science. We use genetics, functional genomics, human-centric disease models and computational biology to develop an unparalleled understanding of cardiometabolic disease and deliver therapies that transform the lives of patients.
You can read more about Novo Nordisk Research Centre Oxford at: http://www.novonordisk.co.uk/about-novo-nordisk-in-uk/oxford-research-centre.html
